Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

    NEXT STORY
    Advanced Wound Dressings Market to Reach US$ 8,460.8 Mn by 2025, Increasing FDA Approvals to Enable Growth, says Fortune Business Insights
    PREV STORY
    RedHill Biopharma to Host Second Quarter 2019 Financial Results Conference Call on July 23, 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Innate Pharma announces its financial calendar for 2017

    INNATE PHARMA ANNOUNCES ITS FINANCIAL CALENDAR FOR 2017 Marseille, France, January 4, 2017 Innate ...

    author_avatar
    NASDAQ Market News

    Biocartis Group NV: Twee Performantiestudies over de Idylla(TM) MSI Biomarkers Geselecteerd voor ASCO Conferentie

    PERSBERICHT: 17 mei 2018, 07:00 CEST Twee Performantiestudies over de Idylla(TM) MSI Biomarkers Geselecteerd ...

    author_avatar
    NASDAQ Market News

    OncoMed Highlights New Data Presented at the American Association for Cancer Research Annual Meeting 2017

    WASHINGTON and REDWOOD CITY, Calif., April 05, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. ...

    author_avatar
    NASDAQ Market News